Monica L Fernández-Quintero
Monica L Fernández-Quintero
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,†,
Patrick K Quoika
Patrick K Quoika
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,†,
Florian S Wedl
Florian S Wedl
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,
Clarissa A Seidler
Clarissa A Seidler
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,
Katharina B Kroell
Katharina B Kroell
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,
Johannes R Loeffler
Johannes R Loeffler
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,
Nancy D Pomarici
Nancy D Pomarici
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,
Valentin J Hoerschinger
Valentin J Hoerschinger
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,
Alexander Bujotzek
Alexander Bujotzek
2
Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany
2,
Guy Georges
Guy Georges
2
Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany
2,
Hubert Kettenberger
Hubert Kettenberger
2
Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany
2,
Klaus R Liedl
Klaus R Liedl
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
1,*
1
Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
2
Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany
✉*Correspondence: Klaus R. Liedl, Klaus.Liedl@uibk.ac.at
†
These authors have contributed equally to this work
This article was submitted to Biological Modeling and Simulation, a section of the journal Frontiers in Molecular Biosciences
Received 2022 Jan 28; Accepted 2022 Jan 31; Collection date 2022.
Keywords: antibodies, structure, interface characterization, interface dynamics, antibody design, bispecific antibody formats
Copyright © 2022 Fernández-Quintero, Quoika, Wedl, Seidler, Kroell, Loeffler, Pomarici, Hoerschinger, Bujotzek, Georges, Kettenberger and Liedl.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.